#viatris — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #viatris, aggregated by home.social.
-
Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy
Japan’s Ministry of Health, Labour and Welfare has approved Viatris’ Wakix (pitolisant) for excessive daytime sleepiness (EDS) related…
#EuropeSays #Japan #JP #approval #excessivedaytimesleepiness #Japanese #narcolepsy #obstructivesleepapnoea #OSAS #PhilippeMartin #Viatris #WAKIX
https://www.europesays.com/japan/93141/ -
Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy
Japan’s Ministry of Health, Labour and Welfare has approved Viatris’ Wakix (pitolisant) for excessive daytime sleepiness (EDS) related…
#EuropeSays #Japan #JP #approval #excessivedaytimesleepiness #Japanese #narcolepsy #obstructivesleepapnoea #OSAS #Viatris #WAKIX
https://www.europesays.com/japan/92977/ -
Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome
Approval Addresses High Unmet Medical Need and Further Advances Viatris’ Innovative Portfolio in Japan PITTSBURGH, Sept. 16, 2026…
#EuropeSays #Japan #JP #controlledsubstance #excessivedaytimesleepiness #globalhealthcarecompany #narcolepsy #OSAS #patients #treatmentoption #Viatris #WAKIX
https://www.europesays.com/japan/92567/ -
https://www.europesays.com/be-nl/139606/ Viatris en Long Chau lanceren een campagne om de effectiviteit van de behandeling van lipidenstoornissen te verbeteren. #Apotheek #apotheker #AziatischeUnie #BE #België #Belgium #CSCE #Gezondheid #Health #Lipiden #LongChau #LongChauVaccinatie #NguyenDoQuyen #Viatris #VietnameseMedischeVereniging
-
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
The recent breakout of Moderna reminded investors that AI stocks aren’t the only destination to make money. Healthcare…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #2028 #AI #BioCryst #FDA #fiscal2026 #ForwardEV/EBITDA #GwynLo #Health #Moderna #MohamedHadji #Q2 #Selatogrel #Viatris
https://www.newsbeep.com/us/834651/ -
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
The recent breakout of Moderna reminded investors that AI stocks aren’t the only destination to make money. Healthcare…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #2028 #AI #BioCryst #FDA #fiscal2026 #ForwardEV/EBITDA #GwynLo #Health #Moderna #MohamedHadji #Q2 #Selatogrel #Viatris
https://www.newsbeep.com/us/834651/ -
https://www.europesays.com/ie/669443/ Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks #2028 #AI #BioCryst #Éire #fda #Fiscal2026 #ForwardEV/EBITDA #GwynLo #Health #HealthCare #Healthcare #IE #Ireland #Moderna #MohamedHadji #Q2 #Selatogrel #Viatris
-
https://www.europesays.com/dk/154736/ Amgen Bets on MrBeast, Novo Builds a Thames Maze: Pharma’s Marketing Reckoning — BigGo Finance #Amelix #Amgen #Biomarin #CannesLions #EliLilly #GileadSciences #JayBradner #MrBeast #Novartis #NovoNordisk #OgilvyHealth #Snapchat #Viatris #ViiVHealthcare #Zayden
-
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
According to reports, on August 6, Harrow, Inc. (NASDAQ:HROW) announced a definitive agreement to acquire global rights to…
#London #Britain #UnitedKingdom #UK #GB #England #Headlines #News #Europe #EU #Harrow #Inc. #TYRVAYA® #Viatris #VTRS
https://www.europesays.com/gbr/london/12050/ -
https://www.europesays.com/it/615381/ Disfunzione erettile: il campanello d’allarme che gli uomini non possono ignorare #EmmanueleAJannini #Health #Iqvia #IT #Italia #Italy #ProntiVia #roma #Salute #SIAMS #SpringerNature #TorVergata #UniversitàDiRomaTorVergata #Viatris
-
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Quick Read Pfizer’s 7% yield and forward P/E of 8 complement Viatris’s three FDA PDUFA decisions arriving before…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #freecashflow #Health #Kimberly-Clark #nyse #Pfizer #top10AIstocks #Viatris
https://www.newsbeep.com/us/749446/ -
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Quick Read Pfizer’s 7% yield and forward P/E of 8 complement Viatris’s three FDA PDUFA decisions arriving before…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #freecashflow #Health #Kimberly-Clark #nyse #Pfizer #top10AIstocks #Viatris
https://www.newsbeep.com/us/749446/ -
Should Viatris’ Japan IgA Nephropathy Win and New Loan Shape VTRS Investors’ Next Move?
Viatris Inc. recently reported positive Phase 3 results in Japan for VR-205 (Nefecon), an IgA nephropathy treatment, and…
#EuropeSays #Japan #JP #IgAnephropathy #MizuhoBank #Viatris
https://www.europesays.com/japan/53838/ -
Viatris VR-205 Phase 3 IgAN Trial Hits Primary Endpoint
VR-205 Met Primary Endpoint and Key Secondary Endpoints and Was Well Tolerated VR-205 Efficacy and Safety Profile in…
#EuropeSays #Japan #JP #budesonide #IgAN #Japanese #nephrology #phase3 #Viatris #VR-205 #VTRS
https://www.europesays.com/japan/49492/ -
https://www.europesays.com/at/244791/ Tertiärprävention bei an MS erkrankten Menschen / DMSG #Angst #AT #Austria #BristolMyers #Depression #DMSG #Forschung #Forschungsförderung #Funktionsstörung #Gesundheit #Harntrakt #Health #Intervalltraining #Lutims #MS #MultipleSklerose #Neuraxpharm #Novartis #Österreich #Projektstart #spenden #Symptome #Tertiärprävention #TheMay50K #Viatris
-
Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled Nationwide
Prescription Medication Medicine Pill TabletsCredit: Getty NEED TO KNOW One type of the prescription anxiety medication Xanax is…
#NewsBeep #News #Medication #anxietymedication #foodanddrugadministration #Health #healthconsequences #UK #UnitedKingdom #Viatris #xanax #XanaxXR
https://www.newsbeep.com/uk/554918/ -
https://www.europesays.com/uk/923882/ Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled Nationwide #AnxietyMedication #FoodAndDrugAdministration #Health #HealthConsequences #Medication #UK #UnitedKingdom #Viatris #xanax #XanaxXR
-
https://www.europesays.com/ie/457202/ Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled Nationwide #AnxietyMedication #Éire #FoodAndDrugAdministration #Health #HealthConsequences #IE #Ireland #Medication #Viatris #Xanax #XanaxXr
-
Anxiety drug Xanax is under recall. Here’s what to know
Xanax, a drug used to treat anxiety disorders, has been placed under a nationwide recall. Viatris, the maker…
#NewsBeep #News #Mentalhealth #coughdrops #DrugEnforcementAdministration #foodanddrugadministration #Health #healthconsequences #MentalHealth #UK #UnitedKingdom #Viatris #xanax #XanaxXR
https://www.newsbeep.com/uk/547496/ -
https://www.europesays.com/ie/450785/ Anxiety drug Xanax is under recall. Here’s what to know #CoughDrops #DrugEnforcementAdministration #Éire #FoodAndDrugAdministration #Health #HealthConsequences #IE #Ireland #MentalHealth #MentalHealth #Viatris #Xanax #XanaxXr
-
https://www.europesays.com/uk/914009/ Anxiety drug Xanax is under recall. Here’s what to know #CoughDrops #DrugEnforcementAdministration #FoodAndDrugAdministration #Health #HealthConsequences #MentalHealth #UK #UnitedKingdom #Viatris #xanax #XanaxXR
-
Anxiety drug Xanax is under recall. Here’s what to know
Xanax, a drug used to treat anxiety disorders, has been placed under a nationwide recall. Viatris, the maker…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #coughdrops #DrugEnforcementAdministration #foodanddrugadministration #Health #healthconsequences #MentalHealth #Viatris #xanax #xanaxxr
https://www.newsbeep.com/us/602309/ -
Anxiety drug Xanax is under recall. Here’s what to know
Xanax, a drug used to treat anxiety disorders, has been placed under a nationwide recall. Viatris, the maker…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #coughdrops #DrugEnforcementAdministration #foodanddrugadministration #Health #healthconsequences #MentalHealth #Viatris #xanax #xanaxxr
https://www.newsbeep.com/us/602309/ -
https://www.europesays.com/ie/445481/ FDA Lists Xanax Recall. Here’s What You Need To Know #alprazolam #anxiety #benzodiazepines #Éire #FailedDissolutionSpecifications #fda #FDAAnnouncesXanaxRecall #Health #IE #Inc #Ireland #Medication #PanicDisorder #USFoodAndDrugAdministration #Viatris #Xanax
-
https://www.europesays.com/uk/907696/ FDA Lists Xanax Recall. Here’s What You Need To Know #Alprazolam #anxiety #benzodiazepines #FailedDissolutionSpecifications #FDA #FDAAnnouncesXanaxRecall #Health #Inc #Medication #PanicDisorder #USFoodAndDrugAdministration #UK #UnitedKingdom #Viatris #xanax
-
FDA Lists Xanax Recall. Here’s What You Need To Know
If you are taking Xanax XR, check whether your medication falls within the lot that’s being recalled. (Photo:…
#NewsBeep #News #Medication #alprazolam #anxiety #benzodiazepines #faileddissolutionspecifications #FDA #FDAAnnouncesXanaxRecall #Health #Inc. #panicdisorder #U.S.FoodandDrugAdministration #UK #UnitedKingdom #Viatris #xanax
https://www.newsbeep.com/uk/541822/ -
Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled Nationwide
Prescription Medication Medicine Pill TabletsCredit: Getty NEED TO KNOW One type of the prescription anxiety medication Xanax is…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #anxietymedication #foodanddrugadministration #Health #healthconsequences #Viatris #xanax #xanaxxr
https://www.newsbeep.com/us/594176/ -
Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled Nationwide
Prescription Medication Medicine Pill TabletsCredit: Getty NEED TO KNOW One type of the prescription anxiety medication Xanax is…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #anxietymedication #foodanddrugadministration #Health #healthconsequences #Viatris #xanax #xanaxxr
https://www.newsbeep.com/us/594176/ -
https://www.europesays.com/uk/898026/ Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled Nationwide #AnxietyMedication #FoodAndDrugAdministration #Health #HealthConsequences #MentalHealth #UK #UnitedKingdom #Viatris #xanax #XanaxXR
-
https://www.europesays.com/ch/31647/ UBS and BofA Lift Price Targets on Viatris (VTRS) #UBS #Viatris
-
Viatris kỷ niệm 25 năm nâng cao sức khỏe tim mạch tại Việt Nam. Theo WHO 2023, bệnh tim mạch là nguyên nhân gây tử vong hàng đầu thế giới, chiếm >75% ở các nước thu nhập trung bình và thấp – gồm Việt Nam. Viatris cam kết hành động để sức khỏe tim mạch tốt hơn mỗi ngày.
#CardiovascularHealth #HeartHealth #Viatris #25Years #Healthcare #WHO2023 #TimMạch #SứcKhỏeTimMạch #Y Tế #VietNam #BảoVệTim
https://vietnamnet.vn/viatris-ky-niem-25-nam-hanh-trinh-nang-cao-suc-khoe-tim-mach-viet-2458281.html
-
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region https://www.byteseu.com/1454406/ #AsiaPacificRegion #ExcessiveDaytimeSleepiness #GlobalHealthcareCompany #InnovativeProducts #Japan #OSAS #Pharma #RegulatoryApproval #StatusEpilepticus #Viatris
-
https://www.alojapan.com/1392924/viatris-completes-acquisition-of-aculys-pharma-including-exclusive-rights-to-pitolisant-in-japan-and-to-spydia-in-japan-and-certain-other-markets-in-the-asia-pacific-region/ Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region #AsiaPacificRegion #ExcessiveDaytimeSleepiness #GlobalHealthcareCompany #InnovativeProducts #Japan #JapanNews #news #OSAS #pharma #RegulatoryApproval #StatusEpilepticus #Viatris Strengthens Viatris’ Presence in Japan With the Addition of Two Innovative Assets Targeting Ar
-
https://www.alojapan.com/1392924/viatris-completes-acquisition-of-aculys-pharma-including-exclusive-rights-to-pitolisant-in-japan-and-to-spydia-in-japan-and-certain-other-markets-in-the-asia-pacific-region/ Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region #AsiaPacificRegion #ExcessiveDaytimeSleepiness #GlobalHealthcareCompany #InnovativeProducts #Japan #JapanNews #news #OSAS #pharma #RegulatoryApproval #StatusEpilepticus #Viatris Strengthens Viatris’ Presence in Japan With the Addition of Two Innovative Assets Targeting Ar
-
@ExTradersGlobal
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020. #Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." ~ September 30, 2021 -
@ExTradersGlobal
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020. #Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." ~ September 30, 2021 -
@ExTradersGlobal
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020. #Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." ~ September 30, 2021 -
@ExTradersGlobal
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020. #Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." ~ September 30, 2021 -
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020.
#Gabapentinoids cost #Medicare $2.1 billion in 2016, as more than 850,000 Medicare beneficiaries were prescribed the drug in that year alone.
#Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." - September 30, 2021
-
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020.
#Gabapentinoids cost #Medicare $2.1 billion in 2016, as more than 850,000 Medicare beneficiaries were prescribed the drug in that year alone.
#Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." - September 30, 2021
-
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020.
#Gabapentinoids cost #Medicare $2.1 billion in 2016, as more than 850,000 Medicare beneficiaries were prescribed the drug in that year alone.
#Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." - September 30, 2021
-
"Her daughter's Lyrica #addiction characterizing her as a once effervescent young woman who began to lose both her spark and control of her behavior — often falling asleep while standing up and acting in other erratic ways — before tragically dying of an #overdose in 2020.
#Gabapentinoids cost #Medicare $2.1 billion in 2016, as more than 850,000 Medicare beneficiaries were prescribed the drug in that year alone.
#Pfizer claims #Viatris a company created in 2020, is responsible for #Lyrica." - September 30, 2021
-
Viatris $VTRS meets earnings expectations with an actual EPS of 0.67, matching the forecast. Revenue comes in slightly below expectations at $3.66B compared to the forecasted $3.7B. #earnings #stockmarket #Viatris
-
Viatris $VTRS meets earnings expectations with an actual EPS of 0.67, matching the forecast. Revenue comes in slightly below expectations at $3.66B compared to the forecasted $3.7B. #earnings #stockmarket #Viatris
-
Viatris $VTRS meets earnings expectations with an actual EPS of 0.67, matching the forecast. Revenue comes in slightly below expectations at $3.66B compared to the forecasted $3.7B. #earnings #stockmarket #Viatris
-
Viatris $VTRS meets earnings expectations with an actual EPS of 0.67, matching the forecast. Revenue comes in slightly below expectations at $3.66B compared to the forecasted $3.7B. #earnings #stockmarket #Viatris
-
Viatris (VTRS) reported earnings pre-market open with an EPS of -$0.64, missing the forecast of $0.65. Revenue stood at $3.84B, slightly below the forecast of $3.88B. Meanwhile, NRG (NRG) reported an EPS of -$1.12, significantly below the forecast of $3.97. Revenue was $28.82B, surpassing the forecast of $8.1B. #Viatris #earnings #premarket #NRG #financials #stockmarket
-
Viatris (VTRS) reported earnings pre-market open with an EPS of -$0.64, missing the forecast of $0.65. Revenue stood at $3.84B, slightly below the forecast of $3.88B. Meanwhile, NRG (NRG) reported an EPS of -$1.12, significantly below the forecast of $3.97. Revenue was $28.82B, surpassing the forecast of $8.1B. #Viatris #earnings #premarket #NRG #financials #stockmarket
-
Wednesday's earnings reports include Salesforce after the closing bell, along with TJX Companies and Viatris before the market open. Investors await insights into the performance of these companies in the software, retail, and pharmaceutical sectors. #earnings #Salesforce #TJXCompanies #Viatris #stockmarket
-
Wednesday's earnings reports include Salesforce after the closing bell, along with TJX Companies and Viatris before the market open. Investors await insights into the performance of these companies in the software, retail, and pharmaceutical sectors. #earnings #Salesforce #TJXCompanies #Viatris #stockmarket
-
FDA puts Innate's lymphoma trials on partial hold after patient death -- Scientists want to put carbon footprints on drugs -- At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide -- See more on our front page news http://bit.ly/w28kSd #fda #clinicaltrials #lymphoma #carbonfootprint #sustainability #viatris #novonordisk #semaglutide #generics #ozempic #wegovy #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma